Institute of Pathology
Inti Zlobec has not added Biography.
If you are Inti Zlobec and would like to personalize this page please email our Author Liaison for assistance.
A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2005 | Pubmed ID: 16061859
VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.
Cancer Dec, 2005 | Pubmed ID: 16222693
The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy.
Cancer Jan, 2006 | Pubmed ID: 16315248
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Sep, 2006 | Pubmed ID: 16741523
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Oct, 2006 | Pubmed ID: 16763611
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
Human pathology Aug, 2006 | Pubmed ID: 16867865
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
American journal of clinical pathology Jan, 2007 | Pubmed ID: 17145638
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
Journal of clinical pathology Oct, 2007 | Pubmed ID: 17182662
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Human pathology Dec, 2011 | Pubmed ID: 21664647
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiology.
Nature clinical practice. Gastroenterology & hepatology Jan, 2007 | Pubmed ID: 17203089
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
European journal of cancer (Oxford, England : 1990) Feb, 2007 | Pubmed ID: 17223543
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Mar, 2007 | Pubmed ID: 17277767
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
European journal of cancer (Oxford, England : 1990) Apr, 2007 | Pubmed ID: 17350821
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
American journal of clinical pathology May, 2007 | Pubmed ID: 17439843
HER2 gene status in primary breast cancers and matched distant metastases.
Breast cancer research : BCR , 2007 | Pubmed ID: 17511881
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.
Virchows Archiv : an international journal of pathology Oct, 2007 | Pubmed ID: 17674041
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Cancer Feb, 2008 | Pubmed ID: 18076013
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2008 | Pubmed ID: 18172264
KIT, PDGFRalpha and EGFR analysis in nephroblastoma.
Virchows Archiv : an international journal of pathology Jun, 2008 | Pubmed ID: 18478259
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2008 | Pubmed ID: 18559598
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2008 | Pubmed ID: 18559599
Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Nov, 2008 | Pubmed ID: 18587323
Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Human pathology Oct, 2008 | Pubmed ID: 18620726
Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
American journal of clinical pathology Nov, 2008 | Pubmed ID: 18854271
Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater.
Virchows Archiv : an international journal of pathology Dec, 2008 | Pubmed ID: 18936968
Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Feb, 2009 | Pubmed ID: 19043399
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
International journal of cancer. Journal international du cancer May, 2009 | Pubmed ID: 19117060
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy.
International journal of cancer. Journal international du cancer Jun, 2009 | Pubmed ID: 19230026
HOX D13 expression across 79 tumor tissue types.
International journal of cancer. Journal international du cancer Oct, 2009 | Pubmed ID: 19488988
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Cancer Sep, 2009 | Pubmed ID: 19517467
Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
Diseases of the colon and rectum Jun, 2009 | Pubmed ID: 19581855
Assessment of mean EGFR gene copy number is a highly reproducible method for evaluating FISH in histological and cytological cancer specimens.
Lung cancer (Amsterdam, Netherlands) May, 2010 | Pubmed ID: 19616866
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
International journal of cancer. Journal international du cancer Mar, 2010 | Pubmed ID: 19697324
Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Human pathology Jan, 2010 | Pubmed ID: 19740518
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
International journal of cancer. Journal international du cancer Jun, 2010 | Pubmed ID: 19856313
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
International journal of cancer. Journal international du cancer Jul, 2010 | Pubmed ID: 19908233
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Histopathology Nov, 2009 | Pubmed ID: 19912362
Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.
Leukemia & lymphoma Feb, 2010 | Pubmed ID: 19925052
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
World journal of gastroenterology : WJG Dec, 2009 | Pubmed ID: 20014453
BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
Histopathology Jan, 2010 | Pubmed ID: 20102401
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
World journal of gastroenterology : WJG Feb, 2010 | Pubmed ID: 20135722
Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
Chest Jul, 2010 | Pubmed ID: 20139227
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
International journal of cancer. Journal international du cancer Dec, 2010 | Pubmed ID: 20162668
Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer.
European journal of cancer (Oxford, England : 1990) May, 2010 | Pubmed ID: 20185297
Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
BMC cancer , 2010 | Pubmed ID: 20222950
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Pathology Apr, 2010 | Pubmed ID: 20350215
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients.
European journal of cancer (Oxford, England : 1990) Aug, 2010 | Pubmed ID: 20542683
Role of tumor size in the pre-operative management of rectal cancer patients.
BMC gastroenterology , 2010 | Pubmed ID: 20550703
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Cancer Oct, 2010 | Pubmed ID: 20572035
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
International journal of cancer. Journal international du cancer Jun, 2011 | Pubmed ID: 20715106
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
Histopathology Aug, 2010 | Pubmed ID: 20716165
Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
Head & neck Feb, 2011 | Pubmed ID: 20848449
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
World journal of gastroenterology : WJG Oct, 2010 | Pubmed ID: 20939111
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
PloS one , 2010 | Pubmed ID: 21179245
Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?
Human pathology May, 2011 | Pubmed ID: 21237492
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.
Human pathology Jul, 2011 | Pubmed ID: 21315418
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
Oncotarget Nov, 2010 | Pubmed ID: 21317460
High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients.
Histopathology Apr, 2011 | Pubmed ID: 21438905
Assessing downgrading of locally advanced rectal cancer after chemo-radiotherapy.
European journal of cancer (Oxford, England : 1990) May, 2011 | Pubmed ID: 21439814
High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death.
Virchows Archiv : an international journal of pathology Jun, 2011 | Pubmed ID: 21538124
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
The Journal of pathology Nov, 2011 | Pubmed ID: 21660972
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Human pathology Dec, 2011 | Pubmed ID: 21664646
Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade.
Histopathology Jun, 2011 | Pubmed ID: 21707712
VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Oct, 2011 | Pubmed ID: 21743435
Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: role of CD24 and CD44 isoforms expression.
Breast (Edinburgh, Scotland) Apr, 2012 | Pubmed ID: 22014860
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Histopathology Sep, 2011 | Pubmed ID: 22034888
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Journal of clinical pathology Feb, 2012 | Pubmed ID: 22130902
Standardization of whole slide image morphologic assessment with definition of a new application: Digital slide dynamic morphometry.
Journal of pathology informatics , 2011 | Pubmed ID: 22200031
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Histopathology Feb, 2012 | Pubmed ID: 22276603
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.
BMC cancer , 2012 | Pubmed ID: 22471961
Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Jul, 2012 | Pubmed ID: 22481282
The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery Feb, 2013 | Pubmed ID: 22588195
Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer.
Frontiers in oncology , 2012 | Pubmed ID: 22655257
Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.
Histopathology Jul, 2012 | Pubmed ID: 22765314
The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
Histopathology Nov, 2012 | Pubmed ID: 22803799
Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Journal of clinical pathology Nov, 2012 | Pubmed ID: 22859396
Role of KCNMA1 in Breast Cancer.
PloS one , 2012 | Pubmed ID: 22899999
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.
International journal of surgical oncology , 2012 | Pubmed ID: 22900161
Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing.
Journal of translational medicine , 2012 | Pubmed ID: 22925370
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Feb, 2013 | Pubmed ID: 23018875
Cancer classification using the Immunoscore: a worldwide task force.
Journal of translational medicine , 2012 | Pubmed ID: 23034130
Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
European journal of cancer (Oxford, England : 1990) Mar, 2013 | Pubmed ID: 23089465
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Human pathology May, 2013 | Pubmed ID: 23159156
Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Cancer cytopathology Aug, 2013 | Pubmed ID: 23408758
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.
European journal of cancer (Oxford, England : 1990) Jun, 2013 | Pubmed ID: 23478000
Novel biomarkers for the prediction of metastasis in colorectal cancer.
Expert opinion on medical diagnostics Mar, 2013 | Pubmed ID: 23530884
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
Endocrine-related cancer Jun, 2013 | Pubmed ID: 23580588
Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
Journal of translational medicine , 2013 | Pubmed ID: 23627766
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
PloS one , 2013 | Pubmed ID: 23734221
The growing galectin network in colon cancer and clinical relevance of cytoplasmic galectin-3 reactivity.
Anticancer research Aug, 2013 | Pubmed ID: 23898060
ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy.
Nature communications , 2013 | Pubmed ID: 23945651
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
Histopathology Mar, 2014 | Pubmed ID: 24111856
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
The Journal of pathology Jan, 2014 | Pubmed ID: 24122236
Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer.
Frontiers in oncology , 2013 | Pubmed ID: 24130965
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
International journal of cancer. Journal international du cancer May, 2014 | Pubmed ID: 24166180
A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.
Annals of surgical oncology Mar, 2014 | Pubmed ID: 24281419
Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.
Immunity Dec, 2013 | Pubmed ID: 24290911
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).
Journal of translational medicine , 2013 | Pubmed ID: 24330423
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.
Neoplasia (New York, N.Y.) Jan, 2014 | Pubmed ID: 24563618
Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains.
Clinical and translational medicine , 2014 | Pubmed ID: 24636624
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival.
Journal of translational medicine , 2014 | Pubmed ID: 24679169
Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients.
Oncotarget Jul, 2014 | Pubmed ID: 25015728
Assessment of Tumor Regression of Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy: Comparison of 2 Commonly Used Scoring Approaches.
The American journal of surgical pathology Aug, 2014 | Pubmed ID: 25140894
Tumor budding in upper gastrointestinal carcinomas.
Frontiers in oncology , 2014 | Pubmed ID: 25177546
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유